FDA Clears First Nebulized LAMA Inhaler for COPD FDA Clears First Nebulized LAMA Inhaler for COPD

Glycopyrrolate inhalation solution 25 mcg twice daily (Lonhala Magnair) is for maintenance treatment of airflow obstruction in adults with chronic obstructive pulmonary disease (COPD).FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

Related Links:

Publication date: Available online 18 October 2018Source: The Lancet Respiratory MedicineAuthor(s): Samy Suissa, Sophie Dell'Aniello, Pierre ErnstSummaryBackgroundLong-acting β2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are the recommended initial maintenance treatment for chronic obstructive pulmonary disease (COPD), with almost all LABAs dispensed in fixed combination with inhaled corticosteroids (LABA-ICS). We compared the effectiveness and safety of LABA-ICS versus LAMA treatment initiation as a function of blood eosinophilia, a potential biomarker of ICS effectiveness, in a real-world settin...
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research
Publication date: Available online 18 October 2018Source: The Lancet Respiratory MedicineAuthor(s): Leonardo M Fabbri, Bianca Beghé, Alberto Papi
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research
Combination drug relaxes airway muscles and trials show it is more effective than either of its components alone.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news
Orthopnea is a symptom rather than a condition. It is a shortness of breath that only occurs when a person is lying down and usually subsides when they sit or stand up. Causes include conditions that affect the heart or lungs, such as heart failure or chronic obstructive pulmonary disease (COPD). Learn more here.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Respiratory Source Type: news
Conclusions Clinicians should consider patient age and history of stroke, peripheral vascular disease, or anxiety/panic disorders when optimizing a lower limb prosthesis users' mobility because these variables may be predictive of modest but clinically meaningful decreased prosthetic mobility. By contrast, common comorbid health conditions such as arthritis, chronic obstructive pulmonary disease, congestive heart failure, and diabetes do not seem predictive of decreased mobility among lower limb prosthesis users.
Source: American Journal of Physical Medicine and Rehabilitation - Category: Rehabilitation Tags: Original Research Articles Source Type: research
This study will be carried out in Nepal, Peru and Uganda, three distinct LMIC settings.Methods/designWe aim to assess the diagnostic accuracy of a simple questionnaire with and without PEF to case-find COPD (GECo1), and examine the effectiveness, cost-effectiveness and implementation of a community-health-worker-supported self-management Action Plan strategy for managing exacerbations of COPD (GECo2). To achieve the first aim, we will enrol a randomly selected sample of up to 10,500 adults aged ≥ 40 years across our three sites, with the goal to enrol 240 participants with moderate-to-severe COPD in to ...
Source: Trials - Category: Research Source Type: clinical trials
ConclusionsThe results suggest that caregivers ’ psychological distress influences caregivers’ mental QoL and patients’ physical QoL. Therefore, health-care professionals should assess and treat anxiety and depression in both members of the COPD dyad to improve their QoL.
Source: Quality of Life Research - Category: Health Management Source Type: research
COPD is a treatable disease with increasing prevalence worldwide. Treatment aims to stop disease progression, to improve quality of life, and to reduce exacerbations. We aimed to evaluate the association of th...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Tags: Research article Source Type: research
.
Source: Acta Clinica Belgica - Category: General Medicine Authors: Source Type: research
A medical technology company out of Alpharetta has acquired Tampa-based Regenerative Medicine Solutions LLC, a biomedical services company in an all-stock transaction. Medovex Corp. was formed to acquire and develop a portfolio of medical tech products and services with disruptive characteristics, the statement said. RMS manages Lung Health Institute, which specializes in cellular therapies to treat chronic obstructive pulmonary disease and other chronic lung di sorders. Bill Horne, and founder…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
More News: Chronic Obstructive Pulmonary | Health